← Back to signals
UTHR
HOLDUnited Therapeutics Corporation
Health Care
1.18
PEGY ratio
Rank #231
Why This Matters
This stock appears fairly valued relative to its growth and dividend yield. Strong projected growth of 17.5% annually over 5 years.
UTHR is fairly valued at 20.6x earnings with 17.5% growth (no dividend) (PEGY 1.18). The stock is priced close to what its growth and income profile would suggest.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-05-29
Valuation
20.6x
P/E Ratio
Growth
17.5%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score1.18
Denominator17.5%
EPS (TTM)$27.05
Market Data
Price$556.82
ExchangeNASDAQ
S&P 500
What Changed
PEGY Score
1.21→1.18(-0.03)
Rank
#235→#231(+4 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only